• Human iPSC-Derived Sensory Neuron Model for HSV-1 Latency

  2026-06-04

  This study establishes a robust protocol for differentiating human inducible pluripotent stem cells into functional sensory neurons and validates their use as a scalable in vitro model for herpes simplex virus 1 (HSV-1) latency and reactivation. These findings address a key gap in translational virology by providing a human neuronal system to dissect the mechanisms underlying HSV-1 latent infection and reactivation, potentially accelerating antiviral research and therapeutic development.

• Lovastatin in Applied Research: Protocols, Workflows, and Op

  2026-06-04

  Lovastatin stands out as a potent HMG-CoA reductase inhibitor with unique applications across cancer, apoptosis, and cell proliferation studies. This guide details evidence-based workflows, troubleshooting strategies, and novel protocol adaptations for maximizing success in high-impact biomedical research.

• EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Mechanisms and Next-Gen Immu

  2026-06-03

  Explore the science and application of EZ Cap™ Mouse IL-12 mRNA (m1Ψ) in immunotherapy research. This article uniquely dissects its molecular advantages, delivery innovations, and the translational impact of recent virus-mimicking delivery systems.

• Leupeptin Hemisulfate Salt: Precision in Protease Activity R

  2026-06-03

  Leupeptin hemisulfate salt is a nanomolar, reversible inhibitor of serine and cysteine proteases. It is widely used for protein degradation studies, viral replication inhibition, and autophagy research. APExBIO’s product offers validated, reproducible performance across biochemical workflows.

• Structure-Based Discovery of SARS-CoV-2 NSP15 Inhibitors

  2026-06-02

  This article reviews a structure-based virtual screening study that identified thymopentin and oleuropein as potent inhibitors of SARS-CoV-2 NSP15, an endoribonuclease involved in viral evasion of host immunity. The findings illustrate the power of computational approaches in expanding the antiviral drug discovery toolkit and highlight new avenues for therapeutic intervention against COVID-19.

• CGF Induces ROS-Mediated Cell Cycle Arrest in Colorectal Can

  2026-06-02

  This study characterizes the anthocyanin derivative CGF, extracted from purple sweet potato, as a potent suppressor of colorectal cancer (CRC) progression. CGF mediates its antitumor effects through ROS-driven metabolic reprogramming, mitochondrial dysfunction, and targeted disruption of cell cycle and apoptosis signaling, highlighting a promising molecular mechanism and preclinical therapeutic strategy.

• Acetoacetic Acid Sodium Salt in Advanced Energy Metabolism R

  2026-06-01

  Acetoacetic acid sodium salt (sodium 3-oxobutanoate) from APExBIO is redefining experimental workflows for diabetes and energy metabolism studies. This article delivers actionable protocols, troubleshooting insights, and cross-domain innovation, enabling researchers to achieve more reproducible and interpretable outcomes.

• SU 5402: Enhancing Cancer and Neuronal Assays with Precision

  2026-06-01

  SU 5402 empowers researchers to dissect receptor tyrosine kinase signaling with high potency, enabling advanced cancer biology and neuron-virology workflows. This article details protocol enhancements, troubleshooting, and translational use-cases for SU-5402, grounded in the latest human iPSC-derived neuron HSV-1 latency validation.

• FGFR Inhibition and ABCB1-Mediated Chemoresistance: Insights

  2026-05-31

  The referenced study demonstrates that infigratinib (BGJ 398), a pan-FGFR inhibitor, can sensitize multidrug-resistant cancer cells to chemotherapeutics by impairing ABCB1-mediated drug efflux. Notably, PD 173074, despite its potent FGFR1/VEGFR2 inhibition, does not share this chemosensitizing activity. These findings clarify distinct roles for FGFR-targeting compounds in overcoming drug resistance, informing future research and experimental tool selection.

• Dihydroartemisinin: Applied Workflows for Antimalarial & mTO

  2026-05-30

  Dihydroartemisinin, a high-purity Artemisia plant extract from APExBIO, enables robust experimental design across malaria and signaling research. This article delivers protocol enhancements, troubleshooting insights, and practical integration of the latest antiplasmodial findings to maximize data confidence.

• Technical Use of Anti-HMGB1 Rabbit Monoclonal Antibody (MA30

  2026-05-29

  The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) addresses the need for specific detection of HMGB1 protein in human, mouse, and rat research samples. This reagent is optimized for Western blot, immunohistochemistry, and flow cytometry, but is not validated for diagnostic or therapeutic workflows.

• LY294002: Precision PI3K Inhibition for Advanced Cancer Rese

  2026-05-29

  LY294002 offers unrivaled flexibility as both a potent PI3K/Akt/mTOR signaling pathway inhibitor and autophagy modulator, making it indispensable for dissecting cell fate mechanisms. This article delivers actionable protocols, expert troubleshooting, and translational insights, empowering researchers to extract robust, reproducible data in oncology and cell biology.

• HyperScribe T7 Cy5 RNA Labeling Kit: Precision Tools for Vir

  2026-05-28

  Explore how the HyperScribe T7 High Yield Cy5 RNA Labeling Kit enables next-generation fluorescent RNA probe synthesis for dissecting viral RNA-protein phase separation, with unique insights into assay optimization and translational research.

• Pol II Degradation Triggers Cell Death Beyond Transcription

  2026-05-28

  This article examines a recent study revealing that targeted degradation of RNA polymerase II (Pol II) initiates cell death in tumor cells independently of transcriptional inhibition. The findings refine our understanding of apoptosis induction and have practical implications for cancer research, especially in designing assays and therapeutic strategies that engage non-transcriptional cell death pathways.

• PD 173074: FGFR1/VEGFR2 Inhibition Redefines Podocyte Resear

  2026-05-27

  Explore the advanced use of PD 173074 in dissecting FGFR signaling for podocyte protection, revealing new directions in diabetic kidney disease research. This in-depth article offers practical assay guidance beyond standard cancer models.

11167 records 1/745 page Next 12345 下5页 Last page